SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-22-061687
Filing Date
2022-05-17
Accepted
2022-05-17 06:55:52
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-17

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tm2214335-3_nt10q.htm NT 10-Q 25275
  Complete submission text file 0001104659-22-061687.txt   26451
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 22932200
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences